500.35 USD
▼-2.35-0.47%
盘后 502.20 +0.37%
2026-09-15
市值
$21.46B
市盈率
17.90
EPS
27.95
股息率
—
52 周区间
396.12 – 609.35
成交量
1.60M
Beta
0.56
目标价
664.33
52W 低 396.1252W 高 609.35
价格走势
公司简介
United Therapeutics Corporation engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. It offers Tyvaso DPI, an inhaled dry powder via pre-filled and single-use cartridges; Nebulized Tyvaso, an inhaled solution via ultrasonic nebulizer; Remodulin (treprostinil) injection to treat patients with pulmonary arterial hypertension to diminish symptoms associated with exercise; Orenitram, a tablet dosage form of tre...